These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7540364)

  • 1. Therapeutic considerations: symptoms, cells and mediators.
    Lightman S
    Allergy; 1995; 50(21 Suppl):10-3; discussion 34-8. PubMed ID: 7540364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seasonal allergic conjunctivitis is accompanied by increased mast cell numbers in the absence of leucocyte infiltration.
    Anderson DF; MacLeod JD; Baddeley SM; Bacon AS; McGill JI; Holgate ST; Roche WR
    Clin Exp Allergy; 1997 Sep; 27(9):1060-6. PubMed ID: 9678838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased plasma levels of nerve growth factor in vernal keratoconjunctivitis and relationship to conjunctival mast cells.
    Lambiase A; Bonini S; Bonini S; Micera A; Magrini L; Bracci-Laudiero L; Aloe L
    Invest Ophthalmol Vis Sci; 1995 Sep; 36(10):2127-32. PubMed ID: 7657550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ocular anti-allergic compounds selectively inhibit human mast cell cytokines in vitro and conjunctival cell infiltration in vivo.
    Galatowicz G; Ajayi Y; Stern ME; Calder VL
    Clin Exp Allergy; 2007 Nov; 37(11):1648-56. PubMed ID: 17877767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ocular allergic disease.
    Stahl JL; Barney NP
    Curr Opin Allergy Clin Immunol; 2004 Oct; 4(5):455-9. PubMed ID: 15349048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune mechanisms in allergic eye diseases: what is new?
    Offiah I; Calder VL
    Curr Opin Allergy Clin Immunol; 2009 Oct; 9(5):477-81. PubMed ID: 19620858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Participation of CD11b and F4/80 molecules in the conjunctival eosinophilia of experimental allergic conjunctivitis.
    Fukushima A; Ishida W; Ojima A; Kajisako M; Sumi T; Yamada J; Tsuru E; Miyazaki J; Tominaga A; Yagita H
    Int Arch Allergy Immunol; 2010; 151(2):129-36. PubMed ID: 19752566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allergic eye disease--a clinical challenge.
    Buckley RJ
    Clin Exp Allergy; 1998 Dec; 28 Suppl 6():39-43. PubMed ID: 9988434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The origin of keratopathy in chronic allergic eye disease: a histopathological study.
    Bacon AS; Tuft SJ; Metz DM; McGill JI; Buckley RJ; Baddeley S; Lightman SL
    Eye (Lond); 1993; 7 ( Pt 3 Suppl )():21-5. PubMed ID: 8253220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mast cell distribution and neutral protease expression in acute and chronic allergic conjunctivitis.
    Baddeley SM; Bacon AS; McGill JI; Lightman SL; Holgate ST; Roche WR
    Clin Exp Allergy; 1995 Jan; 25(1):41-50. PubMed ID: 7728624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vernal keratoconjunctivitis: a severe allergic eye disease with remodeling changes.
    Vichyanond P; Pacharn P; Pleyer U; Leonardi A
    Pediatr Allergy Immunol; 2014 Jun; 25(4):314-22. PubMed ID: 24438133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tear and serum soluble leukocyte activation markers in conjunctival allergic diseases.
    Leonardi A; Borghesan F; Faggian D; Depaoli M; Secchi AG; Plebani M
    Am J Ophthalmol; 2000 Feb; 129(2):151-8. PubMed ID: 10682966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The central role of conjunctival mast cells in the pathogenesis of ocular allergy.
    Leonardi A
    Curr Allergy Asthma Rep; 2002 Jul; 2(4):325-31. PubMed ID: 12044269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic options in ocular allergic disease.
    Hingorani M; Lightman S
    Drugs; 1995 Aug; 50(2):208-21. PubMed ID: 8521755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Allergic conjunctivitis in children].
    Zepeda Ortega B; Rosas Vargas MA; Ito Tsuchiya FM; del Río Navarro BE; Sienra Monge JJ
    Rev Alerg Mex; 2007; 54(2):41-53. PubMed ID: 17542245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic characterization of T cells infiltrating the conjunctiva in chronic allergic eye disease.
    Metz DP; Bacon AS; Holgate S; Lightman SL
    J Allergy Clin Immunol; 1996 Sep; 98(3):686-96. PubMed ID: 8828547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical implications of mast cell involvement in allergic conjunctivitis.
    Elieh Ali Komi D; Rambasek T; Bielory L
    Allergy; 2018 Mar; 73(3):528-539. PubMed ID: 29105783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine production and mRNA expression by conjunctival T-cell lines in chronic allergic eye disease.
    Calder VL; Jolly G; Hingorani M; Adamson P; Leonardi A; Secchi AG; Buckley RJ; Lightman S
    Clin Exp Allergy; 1999 Sep; 29(9):1214-22. PubMed ID: 10469030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tear and conjunctival changes during the allergen-induced early- and late-phase responses.
    Bacon AS; Ahluwalia P; Irani AM; Schwartz LB; Holgate ST; Church MK; McGill JI
    J Allergy Clin Immunol; 2000 Nov; 106(5):948-54. PubMed ID: 11080719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pathophysiology of ocular allergy: current thinking.
    Foster CS
    Allergy; 1995; 50(21 Suppl):6-9; discussion 34-8. PubMed ID: 7785749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.